167 related articles for article (PubMed ID: 24614583)
1. Solid phospholipid nano-particles: investigations into formulation and dissolution properties of griseofulvin.
Brinkmann-Trettenes U; Bauer-Brandl A
Int J Pharm; 2014 Jun; 467(1-2):42-7. PubMed ID: 24614583
[TBL] [Abstract][Full Text] [Related]
2. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
Fong SY; Ibisogly A; Bauer-Brandl A
Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
[TBL] [Abstract][Full Text] [Related]
3. Single step bottom-up process to generate solid phospholipid nano-particles.
Brinkmann-Trettenes U; Barnert S; Bauer-Brandl A
Pharm Dev Technol; 2014 May; 19(3):326-32. PubMed ID: 23528006
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles by spray drying using innovative new technology: the Büchi nano spray dryer B-90.
Li X; Anton N; Arpagaus C; Belleteix F; Vandamme TF
J Control Release; 2010 Oct; 147(2):304-10. PubMed ID: 20659510
[TBL] [Abstract][Full Text] [Related]
6. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
Wong SM; Kellaway IW; Murdan S
Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
[TBL] [Abstract][Full Text] [Related]
8. Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay.
Fischer SM; Buckley ST; Kirchmeyer W; Fricker G; Brandl M
Int J Pharm; 2012 Jan; 422(1-2):52-8. PubMed ID: 22027395
[TBL] [Abstract][Full Text] [Related]
9. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin.
Yang D; Kulkarni R; Behme RJ; Kotiyan PN
Int J Pharm; 2007 Feb; 329(1-2):72-80. PubMed ID: 17027207
[TBL] [Abstract][Full Text] [Related]
10. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
[TBL] [Abstract][Full Text] [Related]
11. Nano-sized flake carboxymethyl cassava starch as excipient for solid dispersions.
Lin X; Gao W; Li C; Chen J; Yang C; Wu H
Int J Pharm; 2012 Feb; 423(2):435-9. PubMed ID: 22197771
[TBL] [Abstract][Full Text] [Related]
12. Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency.
Cutrignelli A; Trapani A; Lopedota A; Franco M; Mandracchia D; Denora N; Laquintana V; Trapani G
AAPS PharmSciTech; 2011 Dec; 12(4):1019-30. PubMed ID: 21826623
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
Rao VM; Lin M; Larive CK; Southard MZ
J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
[TBL] [Abstract][Full Text] [Related]
14. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.
Yamasaki K; Kwok PC; Fukushige K; Prud'homme RK; Chan HK
Int J Pharm; 2011 Nov; 420(1):34-42. PubMed ID: 21864662
[TBL] [Abstract][Full Text] [Related]
15. Influence of spray drying and dispersing agent on surface and dissolution properties of griseofulvin micro and nanocrystals.
Shah DA; Patel M; Murdande SB; Dave RH
Drug Dev Ind Pharm; 2016 Nov; 42(11):1842-50. PubMed ID: 27080146
[TBL] [Abstract][Full Text] [Related]
16. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
17. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.
Figueroa CE; Bose S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1046-55. PubMed ID: 23916460
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications.
Schmid K; Arpagaus C; Friess W
Pharm Dev Technol; 2011 Aug; 16(4):287-94. PubMed ID: 20491538
[TBL] [Abstract][Full Text] [Related]
19. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
20. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
